$KITT
Nauticus Robotics, Inc. Stock $kitt

$kitt Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023087010 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$1.064M	$1.594M	$3.230M
YoY Change	-67.07%	-46.54%
Cost Of Revenue	$4.445M	$2.651M	$3.640M
YoY Change	22.11%	-29.88%
Gross Profit	-$3.381M	-$1.058M	-$420.0K
YoY Change	705.02%	32.25%
Gross Profit Margin	-317.89%	-66.35%	-13.0%
Selling, General & Admin	$3.337M	$6.705M	$6.280M
YoY Change	-46.87%	37.96%	8482.75%
% of Gross Profit
Research & Development	$414.7K	$275.2K	$280.0K
YoY Change	48.1%	13.23%
% of Gross Profit
Depreciation & Amortization	$242.4K	$157.0K	$150.0K
YoY Change	61.57%	-57.55%
% of Gross Profit
Operating Expenses	$3.994M	$275.2K	$6.710M
YoY Change	-40.48%	13.23%	682.31%
Operating Profit	-$7.375M	-$8.198M	-$7.130M
YoY Change	3.43%	35.6%
Interest Expense	-$1.399M	-$957.4K	-$660.0K
YoY Change	111.95%	-168.29%	-114.04%
% of Operating Profit
Other Income/Expense, Net	-$3.934M	-$9.480M	-$440.0K
YoY Change	794.01%	24954.1%
Pretax Income	-$39.54M	-$17.68M	-$8.220M
YoY Change	381.05%	34.13%	-313.88%
Income Tax
% Of Pretax Income
Net Earnings	-$39.54M	-$17.68M	-$8.223M
YoY Change	380.87%	190.59%	-313.96%
Net Earnings / Revenue	-3717.81%	-1109.18%	-254.59%
Basic Earnings Per Share		-$0.43
Diluted Earnings Per Share	-$0.93	-$0.43	-$0.21
COMMON SHARES
Basic Shares Outstanding	50.04M shares	49.82M shares	47.25M shares
Diluted Shares Outstanding		41.16M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$753.4K	$6.772M	$22.70M
YoY Change	-96.68%	-81.14%	-87.01%
Cash & Equivalents	$753.4K	$6.772M	$17.79M
Short-Term Investments	$0.00	$0.00	$5.000M
Other Short-Term Assets	$6.057M	$584.5K	$2.710M
YoY Change	123.48%	-76.58%	3568.65%
Inventory	$2.199M	$13.96M	$6.667M
Prepaid Expenses	$1.889M	$5.126M	$2.393M
Receivables	$212.4K	$997.4K	$1.622M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.221M	$27.87M	$36.96M
YoY Change	-75.05%	-41.89%	6135.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.74M	$26.28M	$15.17M
YoY Change	10.37%	172.4%	955.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$187.5K	$104.9K	$155.5K
YoY Change	20.61%	34.62%	-99.91%
Total Long-Term Assets	$16.93M	$28.47M	$15.64M
YoY Change	8.23%	182.12%	-91.02%
TOTAL ASSETS
Total Short-Term Assets	$9.221M	$27.87M	$36.96M
Total Long-Term Assets	$16.93M	$28.47M	$15.64M
Total Assets	$26.15M	$56.34M	$52.60M
YoY Change	-50.29%	-2.94%	-69.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.035M	$5.713M	$324.5K
YoY Change	2068.2%	105.02%	111.25%
Accrued Expenses	$7.584M	$6.475M	$3.143M
YoY Change	141.3%	452.65%	10554.16%
Deferred Revenue	$2.768M	$152.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.39M	$12.96M	$3.878M
YoY Change	348.4%	197.29%	1062.24%
LONG-TERM LIABILITIES
Long-Term Debt	$31.60M	$29.93M	$15.92M
YoY Change	98.45%	46.49%
Other Long-Term Liabilities	$18.95M	$14.50M
YoY Change		-55.24%
Total Long-Term Liabilities	$50.55M	$44.43M	$15.92M
YoY Change	217.47%	117.49%	99.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.39M	$12.96M	$3.878M
Total Long-Term Liabilities	$50.55M	$44.43M	$15.92M
Total Liabilities	$67.94M	$59.01M	$52.58M
YoY Change	29.22%	102.7%	532.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$118.8M	-$79.25M	-$68.11M
YoY Change	74.42%	50.12%	783.44%
Common Stock	$5.004K	$4.986K	$454.4K
YoY Change	-98.9%	5.52%	105317.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$41.79M	-$2.676M	$27.82K
YoY Change
Total Liabilities & Shareholders Equity	$26.15M	$56.34M	$52.60M
YoY Change	-50.29%	-2.94%	-69.91%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$39.54M	-$17.68M	-$8.223M
YoY Change	380.87%	190.59%	-313.96%
Depreciation, Depletion And Amortization	$242.4K	$157.0K	$150.0K
YoY Change	61.57%	-57.55%
Cash From Operating Activities	-$5.252M	-$3.466M	-$5.740M
YoY Change	-8.5%	-88.74%	2025.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$808.6K	-$4.646M	-$12.40M
YoY Change	-93.48%	-31.78%
Cash From Investing Activities	-$808.6K	-$4.646M	-$12.40M
YoY Change	-93.48%	-31.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	42.50K	10.53M	0.000
YoY Change		-80.11%
NET CHANGE
Cash From Operating Activities	-5.252M	-3.466M	-5.740M
Cash From Investing Activities	-808.6K	-4.646M	-12.40M
Cash From Financing Activities	42.50K	10.53M	0.000
Net Change In Cash	-6.018M	2.414M	-18.14M
YoY Change	-66.82%	-84.25%	6616.03%
FREE CASH FLOW
Cash From Operating Activities	-$5.252M	-$3.466M	-$5.740M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40453015	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41155115	shares
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40611
	dei	Entity Registrant Name EntityRegistrantName	NAUTICUS ROBOTICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1699753
	dei	Entity Address Address Line1 EntityAddressAddressLine1	17146 FEATHERCRAFT LANE
	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 450
	dei	Entity Address City Or Town EntityAddressCityOrTown	WEBSTER
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77598
	dei	City Area Code CityAreaCode	(281)
	dei	Local Phone Number LocalPhoneNumber	942-9069
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50035824	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6771531	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17787159	usd
CY2023Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	400375	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	250375	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	4959263	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	997400	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1622434	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	13960390	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6666912	usd
CY2023Q3	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	26712	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	573895	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5125855	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5046599	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	584492	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	56410	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	27866755	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	36963047	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26275377	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15167367	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2090859	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317208	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	104853	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	155490	usd
CY2023Q3	us-gaap	Assets Assets	56337844	usd
CY2022Q4	us-gaap	Assets Assets	52603112	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5712946	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	324484	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6474818	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3142977	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	152000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	616308	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	410158	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	12956072	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3877619	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14503449	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32688342	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1629516	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87214	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	29925121	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	15922118	usd
CY2023Q3	us-gaap	Liabilities Liabilities	59014158	usd
CY2022Q4	us-gaap	Liabilities Liabilities	52575293	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	625000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	625000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49858194	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47250771	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49858194	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47250771	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	4986	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4725	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	76567814	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	68128196	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-79249114	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68105102	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-2676314	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27819	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56337844	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52603112	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1593854	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2964610	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5542249	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7996734	usd
CY2022Q3	kitt	Service Related Party ServiceRelatedParty	17000	usd
	kitt	Service Related Party ServiceRelatedParty	500	usd
	kitt	Service Related Party ServiceRelatedParty	210400	usd
CY2023Q3	us-gaap	Revenues Revenues	1593854	usd
CY2022Q3	us-gaap	Revenues Revenues	2981610	usd
	us-gaap	Revenues Revenues	5542749	usd
	us-gaap	Revenues Revenues	8207134	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	2651380	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	3781224	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7484249	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8220447	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	160744	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	141901	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	487052	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	370306	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	275154	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	242996	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	984882	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2094278	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6704890	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4861319	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17478099	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8778498	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	9792168	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	9027440	usd
	us-gaap	Costs And Expenses CostsAndExpenses	26434282	usd
	us-gaap	Costs And Expenses CostsAndExpenses	19463529	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8198314	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6045830	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20891533	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11256395	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	133311	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	27980	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1019816	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32692	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3908	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-83654	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	206617	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-56061	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	207146	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-590266	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	8656392	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5963238	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-18775158	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5963238	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-873738	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1402026	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-7365402	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3057660	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9480473	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7130667	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9747521	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8781060	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-17678787	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-13176497	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11144012	usd
	us-gaap	Net Income Loss NetIncomeLoss	-20037455	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.1
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.09
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41155115	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16535661	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40453015	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11983183	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6611457	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	200157	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3504002	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-9915302	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	188657	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3356956	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-13083601	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	14548914	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	669242	usd
CY2022Q3	kitt	Stock Issued During Period Value Of Common Stock For Pipe Investment StockIssuedDuringPeriodValueOfCommonStockForPIPEInvestment	31000000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	12582000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	235593	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-13176497	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	6273167	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27819	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1214863	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	59189	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-14138665	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-12836794	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1862164	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	283390	usd
CY2023Q2	kitt	Stock Issued During Period Exercise Of Warrants StockIssuedDuringPeriodExerciseOfWarrants	338055	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	20673440	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	10320255	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	917993	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3685629	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	78596	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-17678787	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-2676314	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11144012	usd
	us-gaap	Net Income Loss NetIncomeLoss	-20037455	usd
	us-gaap	Depreciation Depreciation	487052	usd
	us-gaap	Depreciation Depreciation	370306	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2928003	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	464779	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3995020	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	624407	usd
	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	590266	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-18775158	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5963238	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	332787	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	145647	usd
	kitt	Interest And Legal Expenses Assumed Into Bridge Note InterestAndLegalExpensesAssumedIntoBridgeNote	528116	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-625034	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-156786	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7293478	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5558996	usd
	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities	-547183	usd
	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities	-409431	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	206702	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	4817187	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	11155980	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9013681	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	152000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-357985	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-241819	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16435894	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31534544	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	10745111	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	6805648	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	4959263	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5785848	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6805648	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	10446884	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	421175	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	17850333	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	14947876	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	338055	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	31000000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	35800000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	12582000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11206114	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53315543	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11015628	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14975351	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17787159	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20952867	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6771531	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35928218	usd
	us-gaap	Interest Paid Net InterestPaidNet	1006993	usd
	us-gaap	Interest Paid Net InterestPaidNet	2108819	usd
	kitt	Capital Expenditures Included In Accounts Payable CapitalExpendituresIncludedInAccountsPayable	849951	usd
	kitt	Capital Expenditures Included In Accounts Payable CapitalExpendituresIncludedInAccountsPayable	1773082	usd
	kitt	Operating Leases At Inception OperatingLeasesAtInception	2016931	usd
	us-gaap	Stock Issued1 StockIssued1	3685440	usd
	kitt	Conversion Of Convertible Debt And Interest Expense To Common Stock ConversionOfConvertibleDebtAndInterestExpenseToCommonStock	14548914	usd
	kitt	Conversion Of Series A Preferred Stock In Connections With Reverse Recapitalization ConversionOfSeriesAPreferredStockInConnectionsWithReverseRecapitalization	3348	usd
	kitt	Conversion Of Series B Preferred Stock In Connection With Reverse Recapitalization ConversionOfSeriesBPreferredStockInConnectionWithReverseRecapitalization	7254	usd
	kitt	Private And Public Warrant Liabilities Assumed In Reverse Recapitalization PrivateAndPublicWarrantLiabilitiesAssumedInReverseRecapitalization	5278145	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. Description of the Business</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Nauticus Robotics, Inc. (“Nauticus,” the “Company,” “our,” “us,” or “we”) is a developer of ocean robots, software, and services delivered in a modern business model to the ocean industry. We were initially incorporated as CleanTech Acquisition Corp. (“CLAQ”) under the laws of the State of Delaware on June 18, 2020. The Company’s principal corporate offices are located in Webster, Texas. Our robotics products and services are delivered to commercial and government-facing customers through a Robotics as a Service (“RaaS”) business model and direct product sales for both hardware platforms and software licenses. Besides a standalone service offering and forward-facing products, our approach to ocean robotics has also resulted in the development of a range of technology products for retrofitting/upgrading legacy systems and other 3<sup>rd</sup> party vehicle platforms. Our services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, and to improve offshore health, safety, and environmental exposure.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Business Combination</i></b><i> – </i>On September 9, 2022 (the “Closing Date”), the Company (prior to the Closing Date, CLAQ) consummated its initial business combination (the “Closing”) pursuant to that certain Agreement and Plan of Merger, dated as of December 16, 2021 (as amended, the “Merger Agreement,” and together with any other agreements and transactions contemplated by the Merger Agreement, the “Business Combination”), with CleanTech Merger Sub, Inc., a Texas corporation and wholly owned subsidiary of CLAQ (“Merger Sub”), and Nauticus Robotics Holdings, Inc. (prior to the Closing Date, “Nauticus Robotics, Inc.”), a Texas corporation (“Nauticus Robotics Holdings”). Pursuant to the terms of the Merger Agreement, a business combination between CLAQ and Nauticus Robotics Holdings was affected through the merger of Merger Sub with and into Nauticus Robotics Holdings, with Nauticus Robotics Holdings surviving the merger as a wholly owned subsidiary of CLAQ. On the Closing Date, CLAQ was renamed “Nauticus Robotics, Inc.” and the previous Nauticus Robotics, Inc. was renamed “Nauticus Robotics Holdings, Inc.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the Closing, among other things, (a) each share of Nauticus Preferred Stock, par value $0.01 per share, that was issued and outstanding immediately prior to the Closing converted into shares of Nauticus Common stock, par value $0.01 per share, (“Nauticus Preferred Stock Conversion”); (b) each of Nauticus Robotic Holdings, Inc.’s unsecured convertible note obligations outstanding was converted into shares of Nauticus Common Stock in accordance with the terms of each such Nauticus Convertible Note (“Nauticus Convertible Notes Conversion”); and (c) each share of Nauticus Common Stock (including shares of Nauticus Common Stock outstanding as a result of the Nauticus Preferred Stock Conversion and Nauticus Convertible Notes Conversion) was converted into the right to receive (i) the per share merger consideration and (ii) Earnout Shares (defined below).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares issued at Closing are summarized as follows (i) an aggregate of 36,650,778 shares of Common Stock, par value $0.0001 (the “Common Stock” of CLAQ prior to the Closing, and the Common Stock of Nauticus following the Closing) shares were issued to holders of Nauticus Common Stock in the Business Combination (ii) the right to receive 7,499,993 additional shares of Common Stock held in escrow pursuant to the terms of the Merger Agreement and as further described below (such additional escrowed shares, the “Earnout Shares”) and (iii) the issuance of 3,100,000 shares of Common Stock for the Equity Financing (as described below). An aggregate of 47,250,771 shares of Common Stock (inclusive of the Earnout Shares) was issued after the Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Former holders of Nauticus Robotics Holdings, Inc. Common Stock are entitled to receive their pro rata share of up to 7,499,993 additional Earnout Shares of Common Stock that were issued and are held in escrow. The Earnout Shares will be released from escrow upon occurrence of the following (each, a “Triggering Event”):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one-half of the Earnout Shares will be released if, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $15.00 per share over any 20 trading days within a 30-day trading period;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one-quarter of the Earnout Shares will be released if, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $17.50 per share over any 20 trading days within a 30-day trading period; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one-quarter of the Earnout Shares will be released if, on or after December 31, 2022, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $20.00 per share over any 20 trading days within a 30-day trading period.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We received proceeds from a private investment in a public entity (“PIPE Investment”), consisting of:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">immediately prior to the Closing, the issuance to certain investors of 3,100,000 shares of Common Stock, for a purchase price of $10.00 per share, and an aggregate purchase price of $31 million (the “Equity Financing”); and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantially concurrent with the closing of the Business Combination, the issuance to certain investors (the “SPA Parties”) pursuant to that certain securities purchase agreement, dated as of December 16, 2021, as amended on January 31, 2022, and as further amended and restated on September 9, 2022 (the “Securities Purchase Agreement”), of secured debentures (the “Debentures”) in an aggregate principal amount of $36,530,320 and associated warrants (the “Original SPA Warrants”), for gross proceeds of $35,800,000. The fair value of the Original SPA Warrants was estimated to be $20,949,110 using a Monte Carlo valuation model incorporating future projections of the various potential outcomes and any exercise price adjustments based on future financing events. The Debentures, which were issued with a 2% original issue discount, are convertible into 2,922,425 shares of Common Stock and the Original SPA Warrants, upon issuance, were exercisable for an additional 2,922,425 shares of Common Stock, with an exercise price equal to $20.00 per share, subject to adjustment. As discussed in further detail below, pursuant to the Letter Agreements (defined below), the exercise price of the Original SPA Warrants was lowered to a weighted average of $3.28 per share, with multiple tranches priced between $2.04 and $4.64 per share (such Original SPA Warrants, upon and following the entry to the Letter Agreements, the “Amended SPA Warrants”). In connection with the exercise of 165,713 Amended SPA Warrants by ATW Special Situations I LLC (“ATW”) in June 2023, 165,713 New SPA Warrants (defined below) were issued to ATW pursuant to its Letter Agreement with the Company. As used in this Form 10-Q, unless context otherwise requires, the term “SPA Warrants” means (i) before the entry into the Letter Agreements, the Original SPA Warrants, and (ii) upon and following the entry into the Letter Agreements, (a) the Amended SPA Warrants, and (b) the warrants that have been issued or are issuable pursuant to the Letter Agreements (the “New SPA Warrants”). See Note 12 for additional information regarding the SPA Warrants.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Business Combination was accounted for as a reverse recapitalization under generally accepted accounting principles in the United States (“GAAP”). Nauticus Robotics Holdings, Inc. was determined to be the accounting acquirer and CLAQ was treated as the acquired company for financial reporting purposes. Accordingly, the financial statements of the combined company represent a continuation of the financial statements of Nauticus Robotics Holdings, Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 9, 2022, the Company received from the Business Combination with CLAQ net cash of $14,947,875. The Company also assumed $30,157 in prepaids, $14,796,942 in accounts payable and accrued liabilities, $850,333 in notes payable and net equity of $(669,243).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CLAQ’s net cash at the Closing Date totaled $14,947,875. This amount, together with proceeds of the PIPE Investment, were available to repay certain indebtedness, transaction costs and for general corporate purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company incurred $12,582,000 in direct and incremental costs associated with the Business Combination and Equity Financing, which primarily consisted of investment banking, legal, accounting, and other professional fees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Impact of COVID-19 Pandemic on Business </i></b><i>– </i>The global spread of COVID-19 and its variants (e.g., the omicron variant) created significant market volatility, economic uncertainty, and disruption during 2021 and 2022 and continuing into 2023. The Company was adversely affected by the deterioration and increased uncertainty in the macroeconomic outlook as a result of the impact of COVID-19. We have experienced and may continue to experience disruptions in our supply chain, due in part to the global impact of the COVID-19 pandemic. Depending upon the duration, including the extent of any residual or further effects, of COVID-19 pandemic-related business interruptions, our customers, suppliers, manufacturers, and partners may suspend or delay their engagements with us, which could result in a material adverse effect on our financial condition and ability to meet current timelines. In addition, the COVID-19 pandemic has affected and may continue to affect our ability to recruit skilled employees to join our team. The conditions caused by the COVID-19 pandemic have adversely affected and may continue to adversely affect, among other things, demand for our products and the ability to test and assess our robotic systems with potential customers, any of which, in turn, could adversely affect our business, results of operations and financial condition. Any further or future impacts of COVID-19 or of another pandemic, epidemic or outbreak of an infectious disease cannot be accurately predicted at this time, and the ultimate direct and indirect impacts on our business, results of operations, and financial condition will depend on future developments that are highly uncertain.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Liquidity</i></b> – Total cash and cash equivalents on hand as of September 30, 2023, was $6.8 million. The Company has incurred recurring losses each year since its inception. The Company may seek funding through additional debt or equity financing arrangements, implement incremental expense reduction measures, or a combination thereof to continue financing its operations. The Company implemented a workforce reduction of 22% on September 29, 2023, which increased costs by $.4 million in the current quarter, which is attributable to severance paid to employees. The cost savings that will be realized over the next twelve months is expected to be $2.7 million. During the third quarter of 2023, the Company received net proceeds of $10.4 million from the issuance of debt. Utilizing cost control measures, cash on hand, revenue from operations, and potential future equity and debt funding, the Company anticipates having sufficient funds to meet its obligations for at least one year from the issuance date of this Form 10-Q. See “Financial Statements – Note 7 – Notes Payable” for additional information on debt capital.</p>
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	7499993	shares
CY2023Q3	kitt	Additional Share Of Common Stock AdditionalShareOfCommonStock	7499993	shares
	us-gaap	Intercompany Agreements Description IntercompanyAgreementsDescription	i.one-half of the Earnout Shares will be released if, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $15.00 per share over any 20 trading days within a 30-day trading period; ii. one-quarter of the Earnout Shares will be released if, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $17.50 per share over any 20 trading days within a 30-day trading period; and iii. one-quarter of the Earnout Shares will be released if, on or after December 31, 2022, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $20.00 per share over any 20 trading days within a 30-day trading period.
CY2023Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	3100000	shares
	us-gaap	Common Stock Convertible Conversion Price Decrease CommonStockConvertibleConversionPriceDecrease	10
	us-gaap	Stockholders Equity Other StockholdersEquityOther	31000000	usd
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	36530320	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	3.28
CY2023Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	165713	shares
CY2022Q3	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	14947875	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	30157	usd
CY2022Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	14796942	usd
CY2022Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	850333	usd
CY2022Q3	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-669243	usd
CY2023Q3	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	14947875	usd
CY2023Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	12582000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	6800000	usd
CY2023Q3	kitt	Workforce Reduction WorkforceReduction	0.22	pure
CY2023Q3	us-gaap	Severance Costs1 SeveranceCosts1	0.4	usd
CY2023Q3	kitt	Liquidation Cost liquidationCost	2.7	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	10.4	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b> – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the (i) estimates of future costs to complete customer contracts recognized over time, (ii) valuation allowances for deferred income tax assets, (iii) valuation of stock-based compensation awards and (iv) the valuation of conversion options, warrants and earnouts. Actual results could differ from those estimates.</p>
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	250000	usd
CY2023Q3	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	250375	usd
CY2022Q3	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	250375	usd
CY2023Q3	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	150000	usd
CY2023Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	4959263	usd
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	936623	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1499030	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	13023767	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5167882	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	13960390	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	6666912	usd
	kitt	Recognized Income Tax RecognizedIncomeTax	0.50	pure
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-83654	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-56061	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	206617	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	207146	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	873816	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	354162	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	615507	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	265650	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Reclassifications</i></b> – Financial statements presented for prior periods include reclassifications that were made to conform to the current-period presentation.</p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Recent Accounting Pronouncements</i></b><i> – </i>In September 2022, the FASB issued ASU 2022-04, Liabilities – Supplier Finance Programs (Subtopic 405-60): Disclosure of Supplier Finance Program Obligations, which requires companies to disclose the use and impact of such programs on a company’s working capital, liquidity, and cash flow. We adopted this standard on January 1, 2023. We do not utilize Supplier Finance Programs and therefore no further disclosure is required. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In June 2016, the FASB issued ASU No. 2016-13, an amendment to ASC 326, <i>Financial Instruments - Credit Losses</i>, which changes the impairment model for certain financial assets that have a contractual right to receive cash, including trade and loan receivables. The new model requires recognition based upon an estimation of expected credit losses rather than recognition of losses when it is probable that they have been incurred. An entity will apply the amendment through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The Company has adopted this standard as of January 1, 2023, and there was no impact on its financial position, results of operations and cash flows upon adoption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In March 2022, the FASB issued ASU No. 2022-02, an amendment to ASC 326, <i>Financial Instruments-Credit Losses</i>, which eliminates the accounting guidance for creditors in troubled debt restructuring. It also aligns conflicting disclosure requirement guidance in ASC 326 by requiring disclosure of current-period gross write-offs by year of origination. The amendment also adds new disclosures for creditors with loan refinancing and restructuring for borrowers experiencing financial difficulty. The Company has adopted this standard as of January 1, 2023, and there was no impact on its financial position, results of operations and cash flows upon adoption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no other new accounting pronouncements that are expected to have a material impact on our condensed consolidated financial statements.</p>
CY2023Q3	us-gaap	Revenues Revenues	1593854	usd
CY2022Q3	us-gaap	Revenues Revenues	2981610	usd
	us-gaap	Revenues Revenues	5542749	usd
	us-gaap	Revenues Revenues	8207134	usd
	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	997400	usd
CY2022	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	1622434	usd
CY2023Q3	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	9963	usd
CY2022Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	9963	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	17827	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	26712	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	573895	usd
	us-gaap	Contract With Customer Asset Sale ContractWithCustomerAssetSale	547183	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	152000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
	kitt	Revenue Recognize RevenueRecognize	1900000	usd
CY2023Q3	kitt	Contract Receivable Retainages Due One To Two Years ContractReceivableRetainagesDueOneToTwoYears	1.9	usd
CY2023Q3	kitt	Contract Receivable Retainages Due Two To Three Years ContractReceivableRetainagesDueTwoToThreeYears	1.3	usd
CY2023Q3	kitt	Contract Receivable Retainages Due Two To Four Years ContractReceivableRetainagesDueTwoToFourYears	0.6	usd
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	2862337	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	2454298	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	1917191	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2392978	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	346327	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	199323	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	5125855	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	5046599	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2480962	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2003341	usd
CY2023Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	24201653	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	12974361	usd
CY2023Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	26275377	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	15167367	usd
CY2023Q3	us-gaap	Interest Income Debt Securities Trading Operating InterestIncomeDebtSecuritiesTradingOperating	1037971	usd
	us-gaap	Interest Income Debt Securities Trading Operating InterestIncomeDebtSecuritiesTradingOperating	2916347	usd
CY2023Q3	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	1740458	usd
CY2022Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	1501736	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	1261385	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	794021	usd
CY2023Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	1629731	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	590936	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1196468	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	171660	usd
CY2023Q3	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	250000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	396777	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	84624	usd
CY2023Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	6474818	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3142977	usd
CY2023Q2	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	1200000	usd
	kitt	Convertible Secured Debentures ConvertibleSecuredDebentures	36530320	usd
CY2022	kitt	Convertible Secured Debentures ConvertibleSecuredDebentures	36530320	usd
	kitt	Convertible Senior Secured Term Loan ConvertibleSeniorSecuredTermLoan	11600000	usd
CY2023Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	48130320	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	36530320	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-18205199	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-20608202	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	29925121	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15922118	usd
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	36530320	usd
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2922425	shares
	kitt	Inclusive Proceeds InclusiveProceeds	35800000	usd
	kitt	Fair Value Debenture Warrants FairValueDebentureWarrants	20949110	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	21679716	usd
	kitt	The Debentures Converted Description TheDebenturesConvertedDescription	The Debentures may be converted at each holder’s option at 120% of the principal amount at a conversion price of $15.00 or 2,922,425 shares of Common Stock, subject to certain adjustments including full ratchet anti-dilution price protections. Interest accrues on the outstanding principal amount of the Debentures at 5% per annum, payable quarterly.
	kitt	Exercisable Initially Par Share ExercisableInitiallyParShare	20
CY2023Q3	kitt	Notes Payable To Related Parties NotesPayableToRelatedParties	5000000	usd
CY2023Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	125000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	125000	usd
CY2023Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.125	pure
CY2023Q4	us-gaap	Longterm Debt Percentage Bearing Fixed Interest Amount LongtermDebtPercentageBearingFixedInterestAmount	125000	usd
	us-gaap	Legal Fees LegalFees	150000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	150000	usd
CY2023Q3	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2026-09-17
CY2022Q3	us-gaap	Long Term Debt Term LongTermDebtTerm	P91Y
CY2022Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2023Q3	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	1	pure
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.0001
CY2023Q2	kitt	Discount Interest Rate DiscountInterestRate	0.15	pure
CY2023Q3	kitt	Discount Interest Rate DiscountInterestRate	0.15	pure
CY2023Q3	kitt	Discount Interest Rate DiscountInterestRate	0.15	pure
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	357985	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	241819	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2090859	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317208	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	616308	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	410158	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1629516	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87214	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2245824	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	497372	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.142	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.079	pure
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	199850	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	194982	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	394811	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	455125	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	477610	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2940247	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4662625	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2416801	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2245824	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	7499993	shares
	kitt	Private Warrants Shares PrivateWarrantsShares	8624991	shares
	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	11.5
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	1636052	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	40973	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	298536	usd
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.286
	us-gaap	Interest Expense InterestExpense	4320690	usd
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.95
CY2023Q3	kitt	Agreed Price Per Share AgreedPricePerShare	2.286
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	635061	usd
CY2023Q2	kitt	Warrant Exercisable Share WarrantExercisableShare	2922425	shares
CY2023Q2	kitt	Aggregate Shares AggregateShares	2922425	shares
CY2023Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	165713	shares
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	165713	shares
CY2023Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	338055	usd
CY2023Q3	kitt	Convertible Loan Agreement Price Per Share ConvertibleLoanAgreementPricePerShare	6
CY2023Q3	us-gaap	Other Noncash Income OtherNoncashIncome	8721515	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	18097987	usd
	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	7789663	shares
	kitt	Business Combination Shares BusinessCombinationShares	279464	shares
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	3970266	shares
	kitt	Continuous Service Percentage ContinuousServicePercentage	0.25	pure
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	948451	usd
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P1Y10M28D
	kitt	Business Combination Conversion Price BusinessCombinationConversionPrice	14.2069
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y8M15D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	104985	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	525465	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	6901057	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	507471	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4458862	usd
	us-gaap	Share Based Goods And Nonemployee Services Transaction Tax Benefit ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit	196711	usd
	us-gaap	Share Based Goods And Nonemployee Services Transaction Tax Benefit ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit	0	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1214580	shares
	kitt	Vested Percentage VestedPercentage	0.51	pure
	kitt	Aggregate Of Shares AggregateOfShares	619438	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y4M13D
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	959104	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3995020	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	235593	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	624407	usd
	kitt	Employees Gross Salaries Percentage EmployeesGrossSalariesPercentage	0.03	pure
CY2022Q3	us-gaap	Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1 PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1	103446	usd
	us-gaap	Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1 PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1	262952	usd
CY2023Q3	us-gaap	Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1 PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1	89854	usd
	us-gaap	Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1 PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1	252166	usd
	kitt	Investment And Securities Description InvestmentAndSecuritiesDescription	(i) $2,500,000 from related party Material Impact Fund II, L.P. (“Material Impact”) as their contribution to the PIPE Investment, (ii) $7,500,000 from related party Schlumberger Technology Corporation as their contribution to the PIPE Investment, (iii) $7,500,000 from related party Transocean Ltd. as their contribution to the PIPE Investment, (iv) $5,000,000 from related party RCB Equities #4, LLC, as their contribution to the PIPE Investment and (v) $1,836,720 from related party SLS Family Irrevocable Trust, $29,591,600 from related party ATW and $5,102,000 from related party Material Impact pursuant to the Securities Purchase Agreement.
	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	29591600	usd
CY2023Q3	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.05	pure
	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	1006993	usd
	kitt	Rra Amendment Description RRAAmendmentDescription	the Company and the SPA Parties entered into the RRA Amendment, pursuant to which, among other things, the Company agreed to issue 1,531,059, 263,976 and 95,031 RRA Amendment Shares to ATW , Material Impact and SLS Family Irrevocable Trust, respectively, in exchange for their waiver and release of any and all claims, remedies, causes of action and any other Initial Effectiveness Date Claims (as defined in the RRA Amendment) under any of the Transaction Documents (as defined in the RRA), including all past and future claims for liquidated damages under the RRA with respect to, and any other amounts that may be payable by reason of or otherwise relating to, the Effectiveness Date (as defined in the RRA) of the Initial Registration Statement. See Note 12 for more information.
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	165713	shares
CY2023Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	165713	shares
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	165713	shares
CY2023Q2	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	338039	usd
CY2023Q3	kitt	Convertible Loan Agreement Price Per Share ConvertibleLoanAgreementPricePerShare	6
CY2023Q3	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	552377	shares
CY2023Q3	us-gaap	Trade Receivables Held For Sale Amount TradeReceivablesHeldForSaleAmount	0	usd
CY2022Q4	us-gaap	Trade Receivables Held For Sale Amount TradeReceivablesHeldForSaleAmount	21000	usd
CY2023Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-17678787	usd
CY2022Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-13176497	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-11144012	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-20037455	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4957366	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4957366	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17678787	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-18133863	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11144012	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24994821	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41155115	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16535661	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40453015	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11983183	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.1
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.09
CY2023Q3	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Stock Options AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptions	3084601	shares
CY2022Q3	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Stock Options AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptions	3934165	shares
	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Stock Options AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptions	3084601	shares
	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Stock Options AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptions	3934165	shares
CY2023Q3	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Restricted And Performance Stock Units AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedAndPerformanceStockUnits	2411602	shares
	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Restricted And Performance Stock Units AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedAndPerformanceStockUnits	2411602	shares
CY2023Q3	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare	19109090	usd
CY2022Q3	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare	18722425	usd
	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare	19109090	usd
	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare	18722425	usd
CY2023Q3	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Earnout Shares AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareEarnoutShares	7499993	shares
CY2022Q3	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Earnout Shares AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareEarnoutShares	7499993	shares
	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Earnout Shares AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareEarnoutShares	7499993	shares
	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Earnout Shares AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareEarnoutShares	7499993	shares
CY2023Q3	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Convertible Debt AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareConvertibleDebt	4855758	usd
CY2022Q3	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Convertible Debt AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareConvertibleDebt	2922425	usd
	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Convertible Debt AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareConvertibleDebt	4855758	usd
	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Convertible Debt AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareConvertibleDebt	2922425	usd
CY2023Q3	kitt	Antidilutive Securities Excluded From Computation Of Earning Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAmount	36961044	usd
CY2022Q3	kitt	Antidilutive Securities Excluded From Computation Of Earning Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAmount	33079008	usd
	kitt	Antidilutive Securities Excluded From Computation Of Earning Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAmount	36961044	usd
	kitt	Antidilutive Securities Excluded From Computation Of Earning Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAmount	33079008	usd
CY2023Q3	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	34	usd
CY2023Q3	us-gaap	Percentage Of Debt Hedged By Interest Rate Derivatives PercentageOfDebtHedgedByInterestRateDerivatives	0.0204	pure
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	kitt	Service Related Party ServiceRelatedParty		usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.09
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11983183	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16535661	shares
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022Q3	kitt	Conversion Of Series B Preferred Stock In Connection With Reverse Recapitalization ConversionOfSeriesBPreferredStockInConnectionWithReverseRecapitalization		usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax		usd
	kitt	Interest And Legal Expenses Assumed Into Bridge Note InterestAndLegalExpensesAssumedIntoBridgeNote		usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	kitt	Operating Leases At Inception OperatingLeasesAtInception		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	kitt	Conversion Of Convertible Debt And Interest Expense To Common Stock ConversionOfConvertibleDebtAndInterestExpenseToCommonStock		usd
	kitt	Conversion Of Series A Preferred Stock In Connections With Reverse Recapitalization ConversionOfSeriesAPreferredStockInConnectionsWithReverseRecapitalization		usd
	kitt	Conversion Of Series B Preferred Stock In Connection With Reverse Recapitalization ConversionOfSeriesBPreferredStockInConnectionWithReverseRecapitalization		usd
	kitt	Private And Public Warrant Liabilities Assumed In Reverse Recapitalization PrivateAndPublicWarrantLiabilitiesAssumedInReverseRecapitalization		usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2022Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent		usd
CY2022	kitt	Convertible Senior Secured Term Loan ConvertibleSeniorSecuredTermLoan		usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.09
CY2022Q3	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Restricted And Performance Stock Units AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedAndPerformanceStockUnits		shares
	kitt	Antidilutive Securities Excluded From Computation Of Earnings Per Share Restricted And Performance Stock Units AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedAndPerformanceStockUnits		shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001849820

Files In Submission

Name	View Source	Status
0001213900-23-087010-index-headers.html	Edgar Link	pending
0001213900-23-087010-index.html	Edgar Link	pending
0001213900-23-087010.txt	Edgar Link	pending
0001213900-23-087010-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_nauticusrobot.htm	Edgar Link	pending
f10q0923ex31-2_nauticusrobot.htm	Edgar Link	pending
f10q0923ex32-1_nauticusrobot.htm	Edgar Link	pending
f10q0923ex32-2_nauticusrobot.htm	Edgar Link	pending
f10q0923_nauticusrobot.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kitt-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
kitt-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
kitt-20230930_def.xml	Edgar Link	unprocessable
kitt-20230930_lab.xml	Edgar Link	unprocessable
kitt-20230930_pre.xml	Edgar Link	unprocessable
f10q0923_nauticusrobot_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KITT
Nauticus Robotics, Inc. Stock $kitt

2023 Q4 Form 10-Q Financial Statement

#000121390023087010 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITT Nauticus Robotics, Inc. Stock $kitt

2023 Q4 Form 10-Q Financial Statement

#000121390023087010 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITT
Nauticus Robotics, Inc. Stock $kitt